rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joshua M. Murray

Director

Company insider

Files Form 4 as: Director, Corcept Therapeutics; Director, Beyond Meat.

Every Form 4 they filed

In numbers

Trades disclosed
11
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
1 Jul 2021
Last trade
21 May 2026
Last filed
26 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CORT Corcept TherapeuticsDirector · Pharmaceuticals · last 21 May 20260 buys · 0 sells
BYND Beyond MeatDirector · Food Products · last 20 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 26 May 2026CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—12,500 at $0.00filing
21 May 2026filed 26 May 2026CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—12,500 at $0.00filing
20 May 2026filed 22 May 2026BYND Beyond MeatFood ProductsSEC FORM 4 Code A—152,555 at $0.00filing
20 May 2026filed 22 May 2026BYND Beyond MeatFood ProductsSEC FORM 4 Code A—152,555 at $0.00filing
10 Jun 2025filed 12 Jun 2025CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—15,000 at $0.00filing
23 May 2024filed 24 May 2024BYND Beyond MeatFood ProductsSEC FORM 4 Code A—35,464 at $0.00filing
23 May 2024filed 24 May 2024BYND Beyond MeatFood ProductsSEC FORM 4 Code A—14,895 at $0.00filing
17 May 2024filed 21 May 2024CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
19 May 2023filed 23 May 2023CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
31 May 2022filed 2 Jun 2022CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—20,000 at $0.00filing
1 Jul 2021filed 2 Jul 2021CORT Corcept Therapeuticsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—60,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

James N. WilsonDirector · Director at Corcept Therapeutics, filing Form 4 there in the last year
Paul Andrew LufkinSenior Vice President, Sales · Senior Vice President, Sales at Beyond Meat, filing Form 4 there in the last year
Lubi KutuaCFO, Treasurer · CFO, Treasurer at Beyond Meat, filing Form 4 there in the last year
Justin Frederick GunnOfficer · Officer at Corcept Therapeutics, filing Form 4 there in the last year
Sean MaduckOfficer · Officer at Corcept Therapeutics, filing Form 4 there in the last year